Opus Point Partners Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Opus Point Partners Management's AMGN Position: Q3 2019 in Review
Opus Point Partners Management increased its Amgen (AMGN) stake by 8.7% in Q3 2019, buying an estimated $23.2K and bringing the position to 1,518 shares worth $294K. The position accounts for 0.53% of the portfolio, ranked #40.
Opus Point Partners Management first reported a position in AMGN in Q4 2014 and has held it in 20 quarters since. The position peaked at $5.81M in Q4 2015. 1,884 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.
- Opus Point Partners Management held 1,518 shares of Amgen worth $294K as of Q3 2019.
- Opus Point Partners Management bought 121 Amgen shares in Q3 2019, an estimated $23.2K.
- Amgen made up 0.53% of Opus Point Partners Management's portfolio in Q3 2019, its #40 holding.
- Opus Point Partners Management first reported a position in Amgen in Q4 2014 and has held it in 20 quarters since.
- Opus Point Partners Management's Amgen position peaked at $5.81M in Q4 2015.
- 1,884 funds tracked by Wall St. Rank held Amgen as of Q3 2019.
Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.